Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M49,430Revenue $M6,300Net Margin (%)19.1Z-Score9.4
Enterprise Value $M47,875EPS $3.3Operating Margin %28.7F-Score7
P/E(ttm))39.0Cash Flow Per Share $4.6Pre-tax Margin (%)27.2Higher ROA y-yY
Price/Book7.310-y EBITDA Growth Rate %15.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales7.45-y EBITDA Growth Rate %27.6Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %10.9ROA % (ttm)12.4Higher Current Ratio y-yN
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)20.3Less Shares Outstanding y-yN
Payout Ratio %5.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNRichard Perry 2014-06-30 Buy 7.8%$116.63 - $173.95
($155.63)
$ 166.127%New holding, 1667625 sh.1,667,625
AGNJohn Paulson 2014-06-30 Buy 4.1%$116.63 - $173.95
($155.63)
$ 166.127%New holding, 5602000 sh.5,602,000
AGNJean-Marie Eveillard 2014-06-30 Buy 0.01%$116.63 - $173.95
($155.63)
$ 166.127%New holding, 30000 sh.30,000
AGNRay Dalio 2014-06-30 Sold Out -0.02%$116.63 - $173.95
($155.63)
$ 166.127%Sold Out0
AGNGeorge Soros 2014-03-31 Sold Out -0.09%$110.28 - $131.43
($121.38)
$ 166.1237%Sold Out0
AGNJoel Greenblatt 2014-03-31 Reduce-0.04%$110.28 - $131.43
($121.38)
$ 166.1237%Reduce -46%18,843
AGNRay Dalio 2014-03-31 Reduce-0.02%$110.28 - $131.43
($121.38)
$ 166.1237%Reduce -54.57%18,499
AGNFrank Sands 2013-12-31 Sold Out -1.9%$88.48 - $110.85
($95.35)
$ 166.1274%Sold Out0
AGNRay Dalio 2013-12-31 Reduce-0.14%$88.48 - $110.85
($95.35)
$ 166.1274%Reduce -81.99%40,719
AGNJoel Greenblatt 2013-12-31 Reduce-0.09%$88.48 - $110.85
($95.35)
$ 166.1274%Reduce -45.01%34,897
AGNJoel Greenblatt 2013-09-30 Add0.1%$84.24 - $92.63
($89.85)
$ 166.1285%Add 113.74%63,459
AGNGeorge Soros 2013-09-30 Buy 0.07%$84.24 - $92.63
($89.85)
$ 166.1285%New holding, 75000 sh.75,000
AGNFrank Sands 2013-09-30 Reduce-0.61%$84.24 - $92.63
($89.85)
$ 166.1285%Reduce -22.67%7,422,715
AGNRay Dalio 2013-06-30 Add0.17%$81.99 - $116.17
($103.71)
$ 166.1260%Add 2759.74%249,341
AGNJoel Greenblatt 2013-06-30 Add0.1%$81.99 - $116.17
($103.71)
$ 166.1260%Add 722.89%29,690
AGNFrank Sands 2013-06-30 Reduce-1.27%$81.99 - $116.17
($103.71)
$ 166.1260%Reduce -24.86%9,598,964
AGNFrank Sands 2013-03-31 Add0.35%$91.73 - $111.89
($106.54)
$ 166.1256%Add 7.38%12,774,895
AGNRay Dalio 2013-03-31 Reduce-0.12%$91.73 - $111.89
($106.54)
$ 166.1256%Reduce -93.77%8,719
AGNJoel Greenblatt 2013-03-31 Reduce-0.08%$91.73 - $111.89
($106.54)
$ 166.1256%Reduce -81.38%3,608
AGNFrank Sands 2012-12-31 Add0.72%$87.95 - $95.26
($91.85)
$ 166.1281%Add 19.46%11,896,641
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN John Paulson 2014-06-305,602,0001.884.1New Buy
AGN Jean-Marie Eveillard 2014-06-3030,0000.010.01New Buy
AGN Richard Perry 2014-06-301,667,6250.567.8New Buy
AGN Mario Gabelli 2014-06-30131,1980.040.12+3.37%
AGN Dodge & Cox 2014-06-303,56400
AGN Joel Greenblatt 2014-06-3016,2810.010.03-13.6%
AGN Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.827.82view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.733.65view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7933.56view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3532.96view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6632.64view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3932.92view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7433.61view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.435.05view
PYOTT DAVID E IChairman of the Board and CEO 2014-02-12Sell252,000$123.1236.45view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5236.01view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
These 6 Top Dividend Stocks Starting To Take Off Sep 09 2014 
Allergan: A ROE That Has Returned to Acceptable Levels Sep 07 2014 
George Soros Reveals His Largest Stake Jul 23 2014 
Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal Apr 25 2014 
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen Apr 23 2014 
Bill Ackman Presentation - Perspective from Allergan's Largest Shareholder Apr 23 2014 
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 
Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 
Stock with High Forward Rate of Return, Donald Yacktman’s Measure Dec 26 2013 


More From Other Websites
Allergan-Valeant Fight Holds Lessons for All Corporate Shareholders Sep 18 2014
Merck Enters into Licensing Agreement with Sun Pharma Sep 18 2014
Valeant's Improving Stock Price Makes its Allergan Bid Look Better Sep 18 2014
Auxilium Mulls Endo Bid; Is $2.2 Billion Enough? Sep 17 2014
Novo Nordisk's Tresiba Effective in Children & Adolescents Sep 17 2014
Valeant’s Last Shot to Woo Owners of Botox Maker Allergan Sep 17 2014
Auxilium Mulls Endo Bid; Street Eyes A Higher Price Sep 17 2014
Faber Report: Dollar General's advance rejected again Sep 17 2014
Valeant, Allergan settle suit Sep 16 2014
Allergan reaches truce with suitors on special shareholder meeting Sep 16 2014
Why It's Time for Allergan Shareholders to Take Some Profits Sep 16 2014
This is what Allergan's move to allow meeting on Valeant takeover means Sep 16 2014
Allergan, Pershing Square Settle: Now What? Sep 16 2014
Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote Sep 16 2014
Faber Report: Allergan special meeting Sep 16 2014
[video] Faber Report: Allergan special meeting Sep 16 2014
Allergan agrees to move forward with meeting Sep 16 2014
Allergan agrees to move forward with meeting Sep 16 2014
Pershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of... Sep 16 2014
Botox Maker Allergan Agrees to Hold Meeting That Could Lead to Takeover Sep 15 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK